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The associations of maternal hypertensive pregnancy disorders with offspring mental 
disorders remain unclear. We examined whether maternal hypertensive disorders and 
maximum blood pressure during pregnancy predict offspring childhood mental disorders, 
whether the associations are independent of maternal and paternal mental disorders and 
paternal hypertensive disorders, independent of or additive with maternal early pregnancy 
overweight/obesity and diabetes disorders, and/or mediated or moderated by preterm birth, 
small-for-gestational-age birth and/or neonatal intensive care unit admission. Our prospective 
study comprised 4743 mother-child dyads of Prediction and Prevention of Preeclampsia and 
Intrauterine Growth Restriction-study. Women were recruited to the study in early pregnancy 
at Finnish maternity hospitals. Children were born 2006─2010 and followed-up until 
12/31/2016, to ages 6.4-10.8-years. Hypertensive pregnancy disorders were identified from 
medical records, Medical Birth Register and Care Register for Health Care. Systolic and 
diastolic blood pressure were measured at antenatal clinics and/or hospital visits. Mental 
disorder diagnoses were identified from Care Register for Health Care. Maternal gestational 
and chronic hypertension, preeclampsia and its severity increased offspring hazard of any 
childhood mental disorder. The associations of preeclampsia (Hazard Ratio=1.66;95% 
Confidence Interval=1.14-2.42) and severe preeclampsia (Hazard Ratio=2.01;95% 
Confidence Interval=1.08-3.73) were independent of all covariates. Maternal hypertensive 
and diabetes disorders and overweight/obesity also additively increased offspring hazard of 
mental disorders. Preterm and small-for-gestational-age births and neonatal intensive care 
unit admission partially mediated the effects of any and severe preeclampsia on offspring 
mental disorders. To conclude, maternal hypertensive pregnancy disorders carry adverse 
consequences for offspring mental health.  
3 




Hypertensive pregnancy disorders, including chronic hypertension, gestational hypertension, 
preeclampsia and eclampsia, are common complicating 5-10% of pregnancies.1-2 They are 
key risk factors for maternal mortality,1-2 stillbirth,1,3 preterm birth1,3 and intrauterine growth 
restriction (IUGR),3 and predict cardiovascular morbidity in the mother and her offspring.1-4  
Increasing evidence suggests that the offspring risk is not confined to perinatal and 
cardiovascular health. Rather, maternal hypertensive pregnancy disorders also predict 
increased offspring risk of mental disorders, psychiatric symptoms and neurodevelopmental 
problems.5–13 According to recent meta-analyses,9,10,12 any maternal hypertensive pregnancy 
disorder, defined as chronic or gestational hypertension or preeclampsia, predicts 1.4-fold 
offspring odds of autism spectrum disorders (ASD) and 1.3-fold odds of attention-deficit-
hyperactivity-disorder (ADHD), with preeclampsia predicting also up to 1.5-fold odds of  
ADHD, ASD and schizophrenia. However, although individual studies suggest significant 
associations of maternal hypertensive pregnancy disorders with offspring developmental 
delay and any mental, mood and anxiety disorders,8,9,12,13 whether maternal hypertensive 
disorders predict also other offspring mental disorders than ASD, ADHD or schizophrenia 
remains quite unexplored. 
Other important knowledge gaps also remain. Firstly, it remains largely unknown whether 
there are dose-response effects: whether offspring mental disorder risk increases with 
increasing severity of maternal preeclampsia or increasing blood pressure during pregnancy. 
In one study, severity of preeclampsia predicted increased offspring risks of ASD and 
developmental delay,11 but another study found that preeclampsia severity did not predict 
ASD or eating disorders.7 Secondly, although hypertensive pregnancy disorders associate 
with poorer maternal mental health,14 familial confounding by maternal mental disorders or 
5 
paternal mental or hypertensive disorders are almost never accounted for in these studies. 
Thirdly, while maternal overweight, obesity and diabetes disorders often co-occur with 
hypertensive disorders,3 and predict offspring mental disorders,15 few studies with 
contradictory findings have assessed whether hypertensive pregnancy disorders associate 
with offspring mental disorders independently of or additively with these conditions.5–8,11,16 
Finally, although hypertensive pregnancy disorders are risk factors for preterm birth, IUGR 
and neonatal complications and illnesses,1,3,17 which all constitute risks for mental 
disorders,17-19 it remains unknown whether preterm birth, IUGR or neonatal health conditions 
mediate or moderate the effects of maternal hypertensive pregnancy disorders on offspring 
mental disorders.  
Hence, to address these gaps in knowledge, we examined among 4743 mother-child dyads, 
whether maternal chronic and gestational hypertension and preeclampsia were associated 
with offspring childhood mental disorders, in a follow-up from birth to 6.4-10.8 years. We 
also studied whether the associations were dose-dependent by categorizing preeclampsia 
according to its severity and examining in a subsample of 1027 mother-child dyads 
associations with maternal maximum systolic (SBP) and diastolic (DBP) blood pressure 
during pregnancy. We further studied whether any associations were independent of maternal 
mental disorders and paternal mental and hypertensive disorders, independent of and/or 
additive with maternal early pregnancy overweight/obesity and diabetes disorders and/or 
mediated or moderated by preterm birth and/or small-for-gestational-age (SGA) birth, 
approximating IUGR, and/or neonatal intensive care unit (NICU) admission, approximating 
neonatal complications and illnesses. 
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METHODS 
Because of the sensitive nature of the data collected for this study, study data cannot be made 
open access. Requests to access the dataset from qualified researchers trained in human subject 
confidentiality protocols may be sent to Prediction and Prevention of Preeclampsia and 
Intrauterine Growth Restriction (PREDO) Study Board. Data requests may require further 
review by national register authorities and ethical committees.20
Our study cohort, PREDO, comprises 4777 women and their singleton children born alive in 
Finland 2006-2010. The cohort profile describes the study design.20 The women were 
recruited to the study at their first ultrasound screen visit at 12-14 gestational weeks at ten 
study hospitals in Southern and Eastern Finland.  
Of the 4777 mother-child dyads, 34 (0.7%) were excluded, since three women withdrew 
consent and 31 dyads lacked data on hypertensive and/or mental disorders. Hence, our study 
sample comprised 4743 mother-child dyads, 99.3% of the original cohort. 
A subsample (n=1079) of this cohort was recruited based on known clinical risk factor status 
for preeclampsia and IUGR.20 This enriched the sample in terms of preeclampsia incidence, 
which in Finland varies between 0.8% and 1.9%.20,21 This subsample had thorough medical 
record data available, including blood pressure data during pregnancy for 1027 of the 1079 
(95.2%; 4.8% with missing data) women.  
All participating women signed informed consent, which enabled linkage of nationwide health 
register data using unique personal identification numbers assigned to all Finnish citizens and 
permanent residents since 1971. The PREDO study protocol was approved by ethical 
committees of Helsinki and Uusimaa Hospital District and study hospitals. 
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Maternal Hypertensive Disorders 
Table S1 in Online Data Supplement (please see http://hyper.ahajournals.org) specifies our 
diagnostic classification of maternal hypertensive disorders, and provides the diagnostic 
criteria,2,22 diagnostic codes and cumulative incidence of these disorders in our sample. We 
grouped hypertensive disorders into five groups: hypertensive disorders only before current 
pregnancy (hypertensive disorders in previous pregnancies or chronic hypertension only 
before current pregnancy), and unspecified hypertension, chronic hypertension, gestational 
hypertension and preeclampsia in current pregnancy. Women with eclampsia, HELLP 
syndrome (hemolysis, elevated liver enzymes, and low platelets) or preeclampsia 
superimposed on chronic hypertension were also included in the preeclampsia group. 
Preeclampsia was further categorized into mild/moderate and severe. Normotensive women 
with no hypertensive disorders before or during current pregnancy constituted the reference 
group (Table S1). 
Hypertensive disorder diagnoses were identified from medical records and two nationwide 
registers; Finnish Care Register for Health Care (HILMO) and Medical Birth Register 
(MBR). HILMO carries all diagnoses of all inpatient (since 1969) and open-ward 
hospitalizations and outpatient treatments in public specialized-care (since 1998) in Finland. 
MBR includes diagnoses from hospital treatments during pregnancy or childbirth since 1987. 
Both registers are validated research tools.23,24 In Finland, International Classification of 
Diseases, Eighth Revision (ICD-8) was used until 1986, ICD-9 in 1987-1995, and ICD-10 
has been used since 1996. 
For women recruited based on known clinical risk factor status, an expert jury comprising 
two physicians and a nurse verified the diagnoses. The register-based diagnoses showed 
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substantial concordance with the clinician-verified diagnoses (Table S2; kappa=0.66, Gwet’s 
AC1 coefficient=0.79).  
Blood Pressure during Pregnancy 
We identified maximum SBP and DBP (mmHg) values during pregnancy from medical 
records. The records comprise measurements conducted at antenatal clinic visits (11-15 visits 
during pregnancy in Finland) and/or hospital visits for suspected hypertensive disorders. 
Most often, public health nurses or midwives conducted the blood pressure measurements 
according to Finnish Current Care Guidelines (https://www.kaypahoito.fi/en): after a five 
minute rest, from the upper arm and in seated position. If blood pressure values were very 
high, the measurements were repeated and the lower value was coded into the medical 
records to avoid white coat hypertension effects. 
Offspring Childhood Mental Disorders 
Mental disorder diagnoses were identified from HILMO with ICD-10 codes F00-F99 from 
birth until 12/31/2016. Table S3 shows the diagnostic codes and cumulative incidences of 
specific mental disorders and medians and interquartile ranges of age at first diagnosis. To 
increase statistical power, we focused on any childhood mental disorder (ICD-10:F00-F99) 
and psychological development disorders (ICD-10:F80-F89) and behavioral and emotional 
disorders (ICD-10:F90-F98) as outcomes, since they were the most frequent. 
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Covariates, additive factors, mediators and moderators 
As covariates, we examined maternal smoking (did not smoke/quit during 1st 
trimester/smoked throughout) and alcohol use (yes/no) during pregnancy, parity 
(primiparous/other), age at delivery (years), education level (primary or secondary/lower 
tertiary/upper tertiary) and lifetime diagnosis of maternal and paternal any mental disorder 
(yes/no; ICD-8 and ICD-9:290-315; ICD-10:F00-F99) and paternal hypertensive disorders 
(yes/no; ICD-8 and ICD-9:40; ICD-10:I1) and offspring sex and birth year. We extracted data 
on maternal smoking, parity and age and offspring sex and birth year from MBR and 
maternal alcohol use and education from early pregnancy self-reports. Lifetime diagnosis of 
maternal and paternal any mental disorder and paternal hypertensive disorders were identified 
from HILMO until 12/31/2016. We identified fathers from population register as male 
spouses married to the mother at childbirth.  
As covariates and additive factors, we examined maternal body mass index (BMI) in early 
pregnancy and diabetes disorders, which we derived from medical records, MBR and 
HILMO. For the sample recruited based on known risk factor status, also diabetes diagnoses 
were jury-verified. Maternal weight and height were measured at first antenatal clinic visits at 
a mean 8.6 (standard deviation=1.5) gestational weeks. BMI was calculated as weight 
(kilograms)/height (meters)2, and categorized into underweight (BMI<18.5), normal weight 
(BMI=18.5-24.9), overweight (BMI=25-29.9) and obese (BMI≥30). Type 1 diabetes (ICD-
9:2500A-2509A; ICD-10:E10), type 2 diabetes (ICD-9:2500B-2509B; ICD-10:E11) and any 
diabetes in current pregnancy (ICD-10:O24) were combined into one category and any 
diabetes in previous pregnancy (ICD-9:6480A, 6488A; ICD-10:O24) into another.  
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As mediators and moderators, we examined preterm birth (<37+0 weeks), SGA birth (birth 
weight<-2 standard deviation units adjusted for sex and gestational age according to national 
growth curves25) and NICU admission (yes/no), which we extracted from MBR.  
Statistics 
With Cox Regression, we estimated the associations of maternal hypertensive disorders, 
preeclampsia severity and maximum blood pressure during pregnancy with any childhood 
mental disorder, psychological development and behavioral and emotional disorders in the 
offspring. In the analyses of hypertensive disorders, normotensive women were the reference 
group.  
To study if associations of maternal hypertensive disorders with offspring childhood mental 
disorders were independent of maternal mental disorders, overweight/obesity and diabetes 
disorders, and paternal mental and hypertensive disorders, we added them as covariates into 
the Cox models. 
We then examined with Cox models the additive effects of maternal hypertensive disorders, 
overweight/obesity and diabetes disorders on offspring childhood mental disorders. For this 
purpose, we summed up if the mother had any hypertensive pregnancy disorder (1=yes; 
0=no), overweight/obesity (1=yes; 0=no) or any diabetes disorder (1=yes; 0=no). The number 
of adverse pregnancy conditions varied from 0 (none of these conditions) to 3 (all three 
conditions). We excluded women who were underweight or had hypertension only before 
current pregnancy or diabetes only in previous pregnancy from these additive effect analyses. 
All these analyses were also adjusted for all maternal, paternal and offspring covariates (see 
Table 1 footnotes). Standard deviations, interquartile ranges and 95% confidence intervals 
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were used as measures of variance. The statistical analyses were conducted with IBM SPSS 
Statistics 24.0-25.0, SAS 9.3 and RStudio-software. 
In sensitivity analyses, we examined whether excluding women with HILMO or MBR 
diagnosis of coronary heart disease (ICD-9:410-414; ICD-10:I20-I25, n=4) or stroke (ICD-
9:430-434, 436-438; ICD-10:I6, n=7) before childbirth or genitourinary infections in current 
pregnancy (ICD-10:O23, n=23) affected our findings. No women had chronic kidney disease 
(ICD-9:585; ICD-10:N18). 
Next, we assessed whether preterm birth, SGA birth and/or NICU admission mediated the 
associations between maternal hypertensive disorders and offspring childhood mental 
disorders, using logistic regressions and Sobel Tests. Mediation was tested only for maternal 
hypertensive disorders independently associated with offspring mental disorders and only if 
the mediator associated with the predictor and outcome variables. To study moderation, we 
examined interaction effects of preterm and SGA births and NICU admission with maternal 
hypertensive disorders on offspring childhood mental disorders. 
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RESULTS 
Table S4 shows the sample characteristics and associations of covariates, additive factors, 
mediators and moderators with maternal hypertensive disorders. In our sample, 200 women 
had chronic hypertension, 4 unspecified hypertension, 263 gestational hypertension and 209 
preeclampsia during current pregnancy and 333 hypertensive disorders only before current 
pregnancy.  
Table S3 shows that 412 (8.7%) offspring were diagnosed with any childhood mental 
disorder during the follow-up. Of them, 256 had psychological development and 200 
behavioral and emotional disorders.  
Maternal and paternal mental disorders, maternal smoking during pregnancy, early pregnancy 
overweight and obesity, diabetes disorders and lower education and offspring’s male sex, 
preterm and SGA birth and NICU admission predicted increased offspring hazard of any 
childhood mental disorder (Table S5). Maternal age, parity and alcohol use during pregnancy 
and paternal hypertensive disorders did not predict offspring childhood mental disorders. 
Maternal Hypertensive Disorders and Offspring Childhood Mental Disorders 
Table 1 shows that maternal chronic hypertension, gestational hypertension and preeclampsia 
in current pregnancy each predicted increased hazard of any childhood mental disorder in the 
offspring. Preeclampsia also predicted offspring psychological development and behavioral 
and emotional disorders, while chronic and gestational hypertension were associated with 
offspring psychological development disorders (Table 1). All associations were independent 
of maternal mental disorders, paternal mental and hypertensive disorders, maternal age, 
parity, smoking, alcohol use and education and offspring covariates. However, only the 
effects of maternal preeclampsia were independent of maternal overweight/obesity and 
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diabetes disorders. Hypertensive disorders only before current pregnancy and unspecified 
hypertension during current pregnancy did not predict offspring childhood mental disorders. 
Severity of Preeclampsia and Offspring Childhood Mental Disorders 
Both severe and mild/moderate preeclampsia in current pregnancy predicted increased 
offspring hazard of any childhood mental, psychological development and behavioral and 
emotional disorders (Table 1). These associations were independent of maternal and paternal 
mental disorders, paternal hypertensive disorders, maternal age, smoking, alcohol use, parity 
and education and offspring covariates. When we adjusted for maternal overweight/obesity 
and diabetes disorders, only severe preeclampsia remained significantly associated with any 
childhood mental and behavioral and emotional disorders. Figure 1 displays these 
associations and shows that offspring hazard of any childhood mental, psychological 
development and behavioral and emotional disorders increased linearly according to 
preeclampsia severity. 
Maternal Blood Pressure during Pregnancy and Offspring Childhood Mental Disorders 
Higher maternal maximum SBP during pregnancy was associated with increased offspring 
hazard of any childhood mental and psychological development disorders, but these 
associations were not independent of covariates (Table 1). Maternal maximum DBP during 
pregnancy did not predict offspring mental disorders.  
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Additive Effects of Maternal Adverse Pregnancy Conditions on Offspring Childhood 
Mental Disorders 
Maternal hypertensive disorders, overweight/obesity and diabetes disorders had additive 
effects increasing offspring hazard of any childhood mental, psychological development and 
behavioral and emotional disorders, independently of maternal and paternal mental disorders, 
paternal hypertensive disorders and other covariates (Figure 2, Table 1). 
Sensitivity Analyses 
Table S6 shows that the effects of maternal hypertensive pregnancy disorders and 
preeclampsia severity and additive effects of adverse pregnancy conditions on offspring 
childhood mental disorders remained unchanged when we excluded women with coronary 
heart disease and stroke diagnosed by childbirth and genitourinary infections during 
pregnancy. 
Mediation and Moderation via Preterm and SGA Births and NICU admission 
Preterm birth, SGA birth and NICU admission each partially mediated the effects of 
preeclampsia and severe preeclampsia on any childhood mental disorder in the offspring 
(Figure 3). SGA birth and NICU admission partially mediated the effects of preeclampsia on 
offspring psychological development disorders and preterm birth and NICU admission of any 
and severe preeclampsia on offspring behavioral and emotional disorders (Figure S1). 
Hypertensive pregnancy disorders did not interact with preterm or SGA births or NICU 
admission in predicting offspring childhood mental disorders (all p-values≥.09). 
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DISCUSSION 
We show here that maternal preeclampsia and its severity increase the hazard of any 
childhood mental disorder, and specifically psychological development and behavioral and 
emotional disorders in the offspring from birth to 6.4-10.8 years. We also show that these 
associations are not explained by maternal mental disorders, age, substance use, parity, 
education, overweight/obesity or diabetes disorders or paternal mental or hypertensive 
disorders. While chronic and gestational hypertension also associate with any childhood 
mental and psychological development disorders in the offspring, these associations do not 
survive adjustments for maternal overweight/obesity and diabetes disorders. However, 
maternal hypertensive disorders, overweight/obesity and diabetes disorders in pregnancy 
additively increase the cumulative incidence of childhood mental disorders from 6.6% to 
22.2% in offspring exposed to none compared to all these three adverse maternal conditions. 
Finally, the effects of preeclampsia and severe preeclampsia on child mental disorders are 
partially mediated by preterm and SGA births and NICU admission.   
Our findings correspond with recent meta-analyses, which, however, were restricted to a few 
neuropsychiatric disorders, namely ASD, ADHD and schizophrenia.9,10,12 We are among the 
first to show that the effects of maternal hypertensive pregnancy disorders are not limited to 
these disorders, but extend to any childhood mental, psychological development and 
behavioral and emotional disorders in the offspring. The observed effect sizes, 1.7-1.9-fold 
increased hazards of any childhood mental disorder, are slightly higher than the previously 
reported 1.3-1.5-fold risks of ASD, ADHD and schizophrenia. The hazards are also slightly 
higher than those related to preterm and SGA births and NICU admission in our sample.   
This is among the first studies to show that maternal hypertensive pregnancy disorders 
predict offspring childhood mental disorders independently of maternal and paternal mental 
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disorders and paternal hypertensive disorders, suggesting that hereditary susceptibility does 
not explain the associations. We are also among the first to show that preeclampsia and its 
severity show associations with offspring mental disorders which are independent of maternal 
overweight/obesity and diabetes disorders. These findings correspond with the few available 
studies which showed similar independent associations of any hypertensive pregnancy 
disorder with child ASD and developmental delay,5 preeclampsia with child ADHD8 and 
ASD,11 and preeclampsia or gestational hypertension with adolescent anxiety disorders6 but 
contrast those of another study which showed no associations of preeclampsia with child 
ASD when controlling for maternal overweight/obesity.16 Furthermore, the severity of 
preeclampsia findings support previous ones on child ASD and developmental delay,11 
although findings are inconsistent.7  
However, the main effects of chronic and gestational hypertension on offspring mental 
disorders were non-significant after adjustment for maternal diabetes and overweight/obesity. 
This suggests shared biological pathways underlying the effects of these maternal conditions 
on offspring mental disorders, for example neuronal brain network hyperexcitability in 
children exposed to maternal cardiovascular dysfunction.26  
Maternal hypertensive pregnancy disorders, overweight/obesity and diabetes disorders also 
had additive effects on offspring mental disorders. Previously, among all children born in 
Finland 2004-2014, maternal severe obesity and type 1 diabetes had additive effects on 
several childhood and adolescence mental disorders.15 Our novel findings suggested that such 
effects are not restricted to severe obesity and type 1 diabetes but extend across the range of 
maternal overweight/obesity, hypertensive and diabetes disorders, suggesting that besides 
cardiovascular dysfunction, maternal metabolic alterations may also affect 
neurodevelopment.  
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We also show that preterm birth, SGA birth and NICU admission partially mediate the effects 
of preeclampsia and severe preeclampsia on offspring childhood mental disorders. 
Correspondingly, low birth weight was recently shown to partially mediate the effects of 
hypertensive pregnancy disorders on offspring childhood depression.13 Children born preterm 
and/or SGA have altered structural brain development, contributing to their increased mental 
disorder risk.17 These alterations may also be among the biological pathways underpinning 
the offspring mental disorder risk associated with maternal preeclampsia.   
Such pathways may also include alterations in placental, immune system and hypothalamic-
pituitary-adrenal (HPA) axis functioning, shared genetic background and/or epigenetic 
changes. Preeclampsia is often characterized by placental insufficiency,21,27 which also 
associates with offspring mental disorders.11 Previous studies show altered HPA axis and 
immune system functioning among women with hypertensive pregnancy disorders28,29 and 
associations of maternal HPA axis activity and inflammation during pregnancy with offspring 
mental disorders.30,31 Evidence also suggests partially shared genetics for hypertension and 
mental disorders,32 and DNA methylation changes in offspring exposed to maternal 
hypertensive pregnancy disorders33 and patients with mental disorders.34
While no universally efficient methods have been developed, international guidelines suggest 
several promising prevention and treatment strategies for hypertensive pregnancy disorders 
and particularly preeclampsia.2,27 These include aspirin, magnesium sulfate, and 
antihypertensive drug treatment, exercise and clinical monitoring of IUGR and preeclampsia 
risks.2,27 Our findings suggest that such interventions may benefit both maternal and offspring 
well-being. 
The strengths of our study include its prospective design, large sample size, validated register 
data on hypertensive and mental disorders and minimal, 0.7% follow-up attrition. We 
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assessed several important covariates, including maternal mental disorders, 
overweight/obesity and diabetes disorders, and paternal mental and hypertensive disorders. 
Study limitations include the observational design, which precludes causal inferences. We 
had maternal blood pressure data only for a subsample, and the associations of maternal 
blood pressure with offspring mental disorders were less consistent than those of 
hypertensive pregnancy disorders, possibly due to limited statistical power. Since this 
subsample was a high-risk sample for preeclampsia and IUGR, blood pressure levels were 
high, which limits generalizability. The electronic medical records contained systematic data 
only on maximum blood pressure values during pregnancy, not values from all 
measurements. This also contributed to the high blood pressure levels, further limiting 
variance, statistical power and generalizability. Larger, population-wide studies using more 
reliable, average blood pressure values across pregnancy should confirm if our findings 
extend to all pregnant women and their offspring. Since our sample was mostly Caucasian in 
a high-income country with universal health care, generalizability to other populations is also 
limited. While we identified all offspring mental disorders until ages 6.4-10.8 years, some 
disorders, including schizophrenia, mood and substance use disorders usually have their onset 
later, in adolescence or adulthood. Hence, our findings generalize best to any childhood 
mental disorder. Furthermore, recent guidelines introduce changes to the diagnostic 
classification of preeclampsia.27,29 Proteinuria is no longer a necessary criterion. Rather, 
preeclampsia is now diagnosed as de novo hypertension after 20 gestational weeks together 
with proteinuria and/or evidence of maternal acute kidney injury, liver dysfunction, 
neurological features, hemolysis, thrombocytopenia, or IUGR.27 The guidelines also suggest 
removal of preeclampsia severity assessment in clinical practice, although acknowledging its 
benefits for research purposes.27,29 Indeed, from the etiological perspective of childhood 





Maternal hypertensive pregnancy disorders, especially preeclampsia and its severity, predict 
increased offspring hazard of any childhood mental disorder. These effects are independent 
of parental mental disorders, paternal hypertensive disorders and several other covariates, 
independent of and additive with maternal overweight/obesity and diabetes disorders, and 
partially mediated by preterm and SGA births and NICU admission. Our findings highlight 
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NOVELTY AND SIGNIFICANCE: 
1) What Is New? We were the first to show that preeclampsia predicts increased offspring
hazard of any childhood mental disorder independently of parental mental disorders, maternal 
overweight/obesity and diabetes disorders and paternal hypertensive disorders. 
2) What Is Relevant? Our findings highlight that hypertensive pregnancy disorders carry
adverse consequences not only for maternal and offspring cardiovascular health, but also for 
offspring mental health. 
Summary: In our prospective study among 4743 mother-child dyads, hypertensive 
pregnancy disorders, especially preeclampsia and its severity, predicted offspring childhood 
mental disorders from birth until ages 6-10 years. 
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FIGURE LEGENDS 
Figure 1. Severity of preeclampsia and offspring childhood mental disorders. 
Cumulative incidences and median ages (interquartile range) at first diagnosis of any 
childhood mental (Panel A), psychological development (Panel B) and behavioral and 
emotional disorders (Panel C) in the offspring of normotensive mothers, mothers with 
mild/moderate preeclampsia and severe preeclampsia, from Kaplan-Meier analyses. P-values 
refer to linear trends from Cox models where preeclampsia severity (0=normotension; 
1=mild/moderate preeclampsia; 2=severe preeclampsia) predicted offspring childhood mental 
disorders, stratifying for offspring sex and adjusting for offspring birth year (model 1), 
maternal age, parity, education, smoking and alcohol use during pregnancy (model 2), 
maternal and paternal mental disorders and paternal hypertensive disorders (model 3) and 
maternal overweight/obesity and diabetes disorders (model 4). 
Figure 2. Additive effects of maternal adverse pregnancy conditions on offspring 
childhood mental disorders.  
Cumulative incidences and median ages (interquartile range) at first diagnosis of any mental 
(Panel A), psychological development (Panel B) and behavioral and emotional disorders 
(Panel C) in the offspring born to mothers with none, one, two or three maternal adverse 
pregnancy conditions (any hypertensive disorder, overweight/obesity, any diabetes disorder), 
from Kaplan-Meier analyses. P-values from Cox models examining the number of adverse 
pregnancy conditions as a linear predictor of offspring mental disorders, stratifying and 
adjusting for the model 1-3 covariates listed in the legend of Figure 1.  
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Figure 3. Preterm birth, small-for-gestational-age birth and neonatal intensive care unit 
admission partially mediate the effects of preeclampsia on offspring childhood mental 
disorders. The figures show the results of Sobel test mediation analyses of preterm birth 
(Panels A-B), small-for-gestational-age birth (Panels C-D) and neonatal intensive care unit 
admission (Panels E-F) as mediators of the effects of preeclampsia and severe preeclampsia 
on any childhood mental disorder in the offspring. Standardized regression coefficients (β) 
and confidence intervals (CI) from unadjusted Sobel tests and logistic regressions. 
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Table 1. Maternal Hypertensive Disorders, Blood Pressure and Adverse Pregnancy 
Conditions and Offspring Hazard of Mental Disorders. 
Offspring Mental Disorders 






HR(95 % CI)* P HR(95% CI)* p HR(95% CI)* p 
Maternal Hypertensive Disorder Only Before Current Pregnancy vs. Normotension 
Model 1 0.76(0.49-1.18) .22 0.85(0.49-1.46) .55 0.50(0.23-1.07) .07 
Model 2 0.80(0.51-1.26) .34 0.89(0.51-1.55) .68 0.56(0.26-1.22) .15 
Model 3 0.79(0.50-1.23) .30 0.87(0.50-1.52) .62 0.55(0.25-1.18) .12 
Model 4 0.75(0.48-1.18) .21 0.83(0.47-1.45) .51 0.52(0.24-1.14) .10 
Maternal Unspecified Hypertension in Current Pregnancy vs. Normotension 
Model 1 3.40(0.48-24.23) .22 5.72(0.80-40.85) .08 0(NA*) .96 
Model 2 3.38(0.47-24.17) .22 5.63(0.78-40.39) .09 0(NA*) .98 
Model 3 3.89(0.54-27.80) .18 6.63(0.92-47.61) .06 0(NA*) .98 
Model 4 3.28(0.46-23.53) .24 5.54(0.77-39.97) .09 0(NA*) .98 
Maternal Chronic Hypertension in Current Pregnancy vs. Normotension 
Model 1 1.57(1.05-2.34) .03 1.92(1.19-3.09) .01 1.43(0.79-2.58) .24 
Model 2 1.57(1.04-2.37) .03 1.89(1.16-3.08) .01 1.54(0.84-2.81) .16 
Model 3 1.60(1.06-2.42) .02 1.95(1.20-3.19) .01 1.60(0.87-2.92) .13 
Model 4 1.24(0.81-1.90) .32 1.48(0.89-2.45) .13 1.18(0.64-2.21) .59 
Maternal Gestational Hypertension in Current Pregnancy vs. Normotension 
Model 1 1.54(1.07-2.21) .02 1.73(1.11-2.69) .02 1.21(0.69-2.14) .50 
Model 2 1.45(1.01-2.08) .05 1.60(1.02-2.51) .04 1.17(0.66-2.06) .60 
Model 3 1.47(1.02-2.12) .04 1.64(1.05-2.57) .03 1.19(0.67-2.10) .56 
Model 4 1.28(0.88-1.85) .20 1.41(0.89-2.22) .14 0.98(0.55-1.76) .95 
Maternal Preeclampsia in Current Pregnancy vs. Normotension 
Model 1 1.89(1.31-2.74) .001 2.16(1.37-3.39) .001 2.21(1.35-3.61) .002 
Model 2 1.93(1.33-2.80) .001 2.23(1.41-3.51) .001 2.26(1.38-3.70) .001 
Model 3 1.92(1.33-2.79) .001 2.21(1.40-3.48) .001 2.29(1.40-3.75) .001 
Model 4 1.66(1.14-2.42) .01 1.87(1.18-2.96) .01 1.96(1.19-3.23) .01 
Maternal Mild/Moderate Preeclampsia in Current Pregnancy vs. Normotension 
Model 1 1.64(0.99-2.72) .05 1.88(1.02-3.45) .04 2.08(1.10-3.95) .03 
Model 2 1.65(1.00-2.74) .05 1.91(1.04-3.53) .04 2.10(1.10-3.99) .02 
Model 3 1.67(1.01-2.76) .05 1.94(1.05-3.57) .03 2.15(1.13-4.09) .02 
Model 4 1.40(0.84-2.34) .19 1.60(0.86-2.97) .14 1.80(0.94-3.45) .08 
Maternal Severe Preeclampsia in Current Pregnancy vs. Normotension 
Model 1 2.25(1.23-4.13) .01 2.40(1.12-5.16) .02 2.96(1.38-6.37) .01 
Model 2 2.42(1.31-4.45) .005 2.69(1.25-5.80) .01 3.24(1.50-7.02) .003 
Model 3 2.31(1.25-4.26) .01 2.54(1.18-5.50) .02 3.12(1.44-6.77) .004 
Model 4 2.01(1.08-3.73) .03 2.15(0.99-4.70) .05 2.76(1.26-6.06) .01 
Maternal Systolic Blood Pressure during Current Pregnancy† 
Model 1 1.21(1.02-1.45) .03 1.30(1.04-1.61) .02 1.19(0.93-1.53) .17 
Model 2 1.16(0.97-1.38) .11 1.24(0.99-1.55) .06 1.13(0.88-1.46) .35 
Model 3 1.18(0.98-1.41) .07 1.27(1.01-1.59) .03 1.14(0.88-1.48) .31 
Model 4 1.11(0.92-1.34) .29 1.17(0.92-1.49) .21 1.06(0.81-1.40) .66 
30 
Maternal Diastolic Blood Pressure during Current Pregnancy† 
Model 1 1.15(0.96-1.38) .13 1.18(0.95-1.49) .14 1.07(0.83-1.39) .59 
Model 2 1.12(0.93-1.34) .24 1.15(0.91-1.45) .23 1.03(0.79-1.35) .82 
Model 3 1.13(0.94-1.35) .20 1.17(0.93-1.46) .19 1.05(0.80-1.37) .74 
Model 4 1.05(0.87-1.28) .61 1.05(0.82-1.35) .67 0.96(0.72-1.27) .77 
Number of Maternal Adverse Pregnancy Conditions‡ 
1 vs. 0 
Model 1 1.48(1.17-1.89) .001 1.48(1.09-2.02) .01 1.42(1.00-2.02) .05 
Model 2 1.43(1.12-1.82) .004 1.42(1.04-1.94) .03 1.39(0.98-1.98) .06 
Model 3 1.42(1.11-1.81) .005 1.42(1.04-1.94) .03 1.37(0.97-1.95) .08 
2 vs. 0 
Model 1 2.06(1.53-2.75) <.001 2.57(1.81-3.64) <.001 2.02(1.33-3.08) .001 
Model 2 1.95(1.45-2.63) <.001 2.43(1.70-3.46) <.001 2.03(1.33-3.11) .001 
Model 3 1.90(1.41-2.55) <.001 2.35(1.64-3.35) <.001 1.95(1.27-2.99) .002 
3 vs. 0  
Model 1 3.28(2.25-4.79) <.001 3.26(1.99-5.32) <.001 3.87(2.32-6.45) <.001 
Model 2 2.99(2.03-4.41) <.001 2.93(1.77-4.84) <.001 3.86(2.28-6.54) <.001 
Model 3 2.94(1.99-4.34) <.001 2.94(1.78-4.88) <.001 3.68(2.16-6.25) <.001 
Model 1 is adjusted for offspring birth year and stratified for offspring sex and Model 2 also for maternal 
education, parity, age, alcohol use and smoking during pregnancy. Model 3 is adjusted further for maternal 
and paternal mental disorders and paternal hypertensive disorders and Model 4 for maternal early pregnancy 
overweight/obesity and diabetes disorders. Participants with missing values on categorical covariates are 
coded into own groups. 
*HR=Hazard Ratio: CI=Confidence Interval: NA=Not Available.
†Systolic blood pressure values are natural logarithm transformed to obtain normality. Diastolic and systolic 
blood pressure are expressed in standard deviation units.  
‡Adverse pregnancy conditions are defined as overweight/obesity, diabetes and hypertensive disorders in 
current pregnancy. Normal weight, normotensive women with no diabetes disorders are the reference group. 
Women who were underweight, had diabetes only in previous pregnancy or hypertensive disorders only 
before current pregnancy are excluded from the additive effect analyses. 
Figure 1. Severity of preeclampsia and offspring childhood mental disorders. 
Figure 2. Additive effects of maternal adverse pregnancy conditions on offspring childhood mental disorders. 
Figure 3. Preterm birth, small-for-gestational-age birth and neonatal intensive care unit admission partially mediate the effects of preeclampsia on offspring childhood mental disorders
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Table S1. The Diagnostic Classification And Incidence of Maternal Hypertensive Pregnancy Disorders. 
Hypertensive Disorder Who Is Included? Diagnostic Criteria ICD-codes Number of 
cases (%) 
Normotension Normotensive women with no diagnosis of chronic 
hypertension by childbirth and no diagnosis of 
hypertensive pregnancy disorders in previous or current 
pregnancy. 
- - 3734(78.7%) 
Hypertension Only Before 
Current Pregnancy 
Women diagnosed either with hypertensive pregnancy 
disorders in previous pregnancies or with chronic 
hypertension only before the current pregnancy started. 
These women had no hypertensive disorder diagnosis in 
the current pregnancy. 
Has fulfilled the criteria for any of the 
specific disorders listed below, but only 







Unspecified Hypertension in 
Current Pregnancy 
Women diagnosed with unspecified hypertension in 
current pregnancy. 
Transient hypertension during current 
pregnancy. 
ICD-10:O16 4(0.1%) 
Chronic Hypertension in 
Current Pregnancy 
Women diagnosed with chronic hypertension during the 
current pregnancy. 
Blood pressure ≥140/90 mmHg 
SBP/DBP present from pre-pregnancy or 




Gestational Hypertension in 
Current Pregnancy 
Women diagnosed with gestational hypertension in the 
current pregnancy. 
Newly elevated blood pressure (≥140/90 
mmHg SBP/DBP) at ≥20 gestational 
weeks without proteinuria. 
ICD-10:O13 263(5.5%) 
Preeclampsia in Current 
Pregnancy 
Women diagnosed with preeclampsia, superimposed 
preeclampsia, eclampsia or HELLP syndrome in the 
current pregnancy 
Newly elevated blood pressure (≥140 
mmHg SBP and/or ≥90 mmHg DBP) at 
≥20 gestational weeks combined with 
proteinuria (urinary excretion of ≥0.3 g 
protein in a 24-hour specimen or at least 






/Moderate Preeclampsia in 
Current Pregnancy 
Women diagnosed with mild/moderate preeclampsia in 
current pregnancy. 
Completes the criteria of preeclampsia 
but not severe preeclampsia. 
ICD-10:O14.0 122(2.6%) 
Severe Preeclampsia in 
Current Pregnancy 
Women diagnosed with severe preeclampsia in current 
pregnancy. 
SBP≥160 mmHg, DBP≥110 mmHg, 
and/or ≥5g proteinuria in a 24-h urine 
collection. 
ICD-10:O14.1 63(1.3%) 
ICD=International Classification of Diseases. SBP=systolic blood pressure. DBP=diastolic blood pressure. HELLP= hemolysis, elevated liver enzymes, and low platelets. 
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Table S2. The diagnostic concordance of maternal hypertensive pregnancy disorder diagnoses in the current 
pregnancy in the Finnish Care Register for Health Care (HILMO) and Medical Birth Register (MBR) with diagnoses 
verified by a clinical jury of two clinicians and a nurse. Kappa-coefficient=0.66 and Gwet’s AC1 coefficient=0.79 both 
















HILMO or MBR 
N(%) N(%) N(%) N(%) 
Normotension 
(n=599) 
528(97.1%) 36(22.5%) 30(38.0%) 5(7.0%) 
Chronic Hypertension 
in Current Pregnancy 
(n=101) 
2(0.4%) 90(56.3%) 5(6.3%) 4(5.6%) 







9(1.7%) 19(11.9%) 9(11.4%) 53(74.6%) 
The table shows the number and percentage of women in each jury-verified diagnostic category based on the Medical Birth 
Register (MBR) and Care Register for Health Care (HILMO) diagnostic groups. Women with unspecified hypertensive 
disorder in the current pregnancy in the HILMO or MBR and women with hypertensive disorders only before current 
pregnancy in case reports, HILMO or MBR were excluded from these analysis. 
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Table S3. Mental Disorders in the Offspring. The number and percentage of offspring with different mental disorders and the median (mdn) age (in years) at the time of first diagnosis and its 
interquartile range (IQR) in the total sample and in the hypertensive disorder groups and the International Classification of Diseases, Ninth (ICD-9) and Tenth Revision (ICD-10) diagnostic codes 
used to identify the different diagnoses. 




























Diagnostic Outcome in the 
Offspring 
N (%) 3734(78.7%) 333(7.7%) 4(0.1%) 200(4.2%) 263(5.5%) 209(4.4%) 122(2.6%) 63(1.3%) 
ICD-10 N (%) / 
Mdn (IQR), y* 
N (%) / 
Mdn (IQR), y* 
N (%)/ 
Mdn (IQR), y* 
N (%) / 
Mdn (IQR), y* 
N (%) / 
Mdn (IQR), y* 
N (%) / 
Mdn (IQR), y* 
N (%) / 
Mdn (IQR), y* 
N (%) / 
Mdn (IQR), y* 
N (%) / 
Mdn (IQR), y* 
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*Mdn=median; IQR= interquartile range; y=years. †NA=Not available.
For cells with less than 4 participants, no median age or IQR is given to protect participant anonymity and since IQR could not be calculated in these groups. 
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Table S4. The Sample Characteristics and Associations between Covariates and Maternal Hypertensive Disorders. Means and standard deviations in hypertensive 
disorder groups for continuous covariates and number and percentage of participants with hypertensive disorders for categorical covariates. Median ages at first diagnosis 
and its interquartile ranges for diagnostic entities. P-values from chi-squared, Kruskal-Wallis and ANOVA-tests. 


















N(%) 3734(78.7%) 333(7.0%) 4(0.1%) 200(4.2%) 263(5.5%) 209(4.4%) 













Age at Delivery (years) 31.2(4.8) 32.2(4.5) 33.7(3.2) 34.4(5.1) 32.2 (5.2) 31.5 (5.1) <.001 
Education Level 
  Primary or Secondary 1376(40.2%) 123(40.5%) 2(50.0%) 97(50.5%) 114(45.6%) 76(39.4%) 
.02   Lover Tertiary 871(25.5%) 85(28.0%) 1(25.0%) 42(21.9%) 73(29.2%) 61(31.6%) 
  Upper Tertiary 1172(34.3%) 96(31.6%) 1(25.0%) 53(27.6%) 63(25.2%) 56(29.0%) 
 Data Missing 315(8.4%) 29(8.7%) 0(0.0%) 8(4.0%) 13(4.9%) 16(7.7%) .04 
Parity 
  Primiparous 1542(41.3%) 6(1.8%) 3(75.0%) 78(39.0%) 116(44.9%) 97(46.4%) <.001 
  Multiparous 2192(58.7%) 327(98.2%) 1(25.0%) 122(61.0%) 147(55.1%) 112(53.6%) 
Alcohol Use during Pregnancy 
  Yes 437(15.7%) 35(14.6%) 3(100.0%) 30(17.6%) 31(15.3%) 166(10.5%) .51 
  No 2344(84.3%) 205(85.4%) 0(0.0%) 140(82.4%) 171(84.7%) 13(89.5%) 
 Data Missing 953(25.5%) 93(27.9%) 1(25.0%) 30(15.0%) 61(23.2%) 57(27.3%) .02 
Smoking During Pregnancy 
  Did Not Smoke 3389(91.2%) 309(93.4%) 4(100.0%) 186(93.5%) 240(91.3%) 191(91.8%) 
.69   Quit during 1st Trimester 128(3.4%) 11(3.3%) 0(0.0%) 6(3.0%) 7(2.7%) 10(4.8%) 
  Smoked Throughout 197(5.3%) 11(3.3%) 0(0.0%) 7(3.5%) 16(6.1%) 7(3.4%) 
 Data Missing 20(0.5%) 2(0.6%) 0(0.0%) 1(0.5%) 0(0.0%) 1(0.5%) .91 
Early Pregnancy Body Mass Index [weight (kilograms) / height (meters)2] 
  Continuous 23.9(4.5) 25.3(5.8) 26.3(5.9) 29.4(6.4) 26.4(5.8) 26.8(6.4) <.001 
  Underweight 141(3.8%) 7(2.1%) 0(0.0%) 1(0.5%) 5(1.9%) 5(2.4%) 
<.001   Normal Weight 2504(67.1%) 193(58.0%) 2(50.0%) 61(30.5%) 135(51.3%) 93(44.5%) 
  Overweight 694(18.6%) 80(24.0%) 1(25.0%) 46(23.0%) 51(19.4%) 57(27.3%) 
  Obese 395(10.6%) 53(15.9%) 1(25.0%) 92(46.0%) 72(27.4%) 54(25.8%) 
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Diabetes 
<.001   No diabetes 3301(88.4%) 257(77.2%) 3(75.0%) 115(57.5%) 197(74.9%) 156(74.6%) 
  Diabetes in Previous Pregnancy 53(1.4%) 16(4.8%) 0(0.0%) 5(2.5%) 11(4.2%) 6(2.9%) 
  Diabetes in Current Pregnancy  380(10.2%) 60(18.0%) 1(25.0%) 80(40.0%) 55(20.9%) 47(22.5%) 
Systolic Blood Pressure (mm/hg) 126.5(11.0) 131.9(12.3) 139.5(2.1) 153.2(16.3) 150.4(14.0) 168.2(19.5) <.001 
  Data Missing 3226(86.4%) 183(55.0%) 2(50.0%) 39(19.5%) 155(58.9%) 111(53.1%) <.001 
Diastolic Blood Pressure (mm/hg) 81.9(8.0) 85.5(7.2) 90.0(7.1) 100.6(9.2) 99.3(7.7) 104.7(10.6) <.001 
  Data missing 3226(86.4%) 183(55.0%) 2(50.0%) 39(19.5%) 155(58.9%) 111(53.1%) <.001 
Lifetime Diagnosis of Any Mental Disorder 
  No 3113(83.4%) 275(82.6%) 4(100.0%) 169(84.5%) 221(84.0%) 172(82.3%) .93 
  Yes 621(16.6%) 58(17.4%) 0(0.0%) 31(15.5%) 42(16.0%) 37(17.7%) 
 Median age at first diagnosis (IQR†) 27.7(20.0-34.0) 30.0(21.5-34.3) NA‡ 33.4(27.2-39.4) 27.2(19.2-36.1) 27.1(18.4-35.7) .04 
Paternal Characteristics 
Lifetime Diagnosis of Any Mental Disorder 
  No 1721(92.6%) 164(94.8%) 2(100.0%) 105(96.3%) 133(95.0%) 92(90.2%) .37 
  Yes 138(7.4%) 9(5.2%) 0(0.0%) 4(3.7%) 7(5.0%) 10(9.8%) 
 Data missing 1875(50.2%) 160(48.0%) 2(50.0%) 91(45.5%) 123(46.8%) 107(51.2%) .66 
 Median age at first diagnosis (IQR†) 27.1(20.2-34.9) 28.7(21.8-35.2) NA‡ 28.7(21.8-35.2) 20.5(13.9-38.3) 22.5(19.1-31.7) .18 
Lifetime Diagnosis of Any Hypertensive Disorder 
  No 
Y
1826(98.2%) 169(97.7%) 2(100.0%) 107(98.2%) 134(95.7%) 100(98.0%) .49 
  Yes 33(1.8%) 4(2.3%) 0(0.0%) 2(1.8%) 6(4.3%) 2(2.0%) 
 Data missing 1875(50.2%) 160(48.0%) 2(50.0%) 91(45.5%) 123(46.8%) 107(51.2%) .66 
     Median age at first diagnosis (IQR†) 40.6(34.1-44.5) 36.4(32.3-39.6) NA‡ NA‡ 20.5(13.9-38.3) NA‡ .22 
Child Characteristics 
Birth Year 2008.4(0.7) 2008.1(0.9) 2008.0(0.8) 2008.0(0.9) 2008.2(0.9) 2008.2(0.9) <001 
 2006 18(0.5%) 18(5.4%) 0(0.0%) 14(7.0%) 12(4.6%) 8(3.8%) 
<.001 
 2007 332(8.9%) 47(14.1%) 1(25.0%) 34(17.0%) 40(15.2%) 30(14.4%) 
 2008 1821(48.8%) 162(48.6%) 2(50.0%) 98(49.0%) 118(44.9%) 94(45.0%) 
 2009 1342(35.9%) 97(29.1%) 1(25.0%) 53(26.5%) 81(30.8%) 70(33.5%) 
 2010 221(5.9%) 9(2.7%) 0(0.0%) 1(0.5%) 12(4.6%) 7(3.3%) 
Sex 
  Girl 1800(48.2%) 160(48.0%) 1(25.0%) 85(42.5%) 120(45.6%) 101(48.3%) .47 
  Boy 1934(51.8%) 173(52.0%) 3(75.0%) 115(57.5%) 143(54.4%) 108(51.7%) 
7 
Gestational Age (weeks) 40.0(1.5) 39.7(1.5) 40.1(1.0) 39.6(1.6) 39.9(1.7) 38.3(2.8) <.001 
  Preterm Birth 113(3.0%) 12(3.6%) 0(0.0%) 8(4.0%) 11(4.2%) 45(21.5%) <.001 
  Other (≥37) weeks) 3617(97.0%) 321(96.4%) 4(100.0%) 192(96.0%) 252(95.8%) 164(78.5%) 
 Data Missing 4(0.1%) 0(0.0%) 0(0.0%) 0(0.0%) 0(0.0%) 0(0.0%) .96 
Birth Weight Adjusted for Sex and Gestational Age 
  SD score -0.04(0.95) 0.14(0.94) -0.05(0.21) -0.19(1.03) -0.16(1.11) -0.54(1.27) <.001 
 Small for gestational age 52(1.4%) 5(1.5%) 0(0.0%) 9(4.5%) 12(4.6%) 27(12.9%) <.001 
 Other 3675(98.6%) 327(98.5%) 4(100.0%) 191(95.5%) 251(95.4%) 182(87.1%) 
    Data Missing 7(0.2%) 1(0.3%) 0(0.0%) 0(0.0%) 0(0.0%) 0(0.0%) .91 
Neonatal Intensive Care Unit Admission 
  Yes 286(7.7%) 26(7.8%) 0(0.0%) 30(15.6%) 31(11.8%) 55(26.3%) <.001 
  No 3438(92.3%) 307(92.2%) 4(100.0%) 162(84.4%) 232(88.2%) 154(77.7%) 
 Data Missing 10(0.3%) 0(0.0%) 0(0.0%) 8(4.0%) 0(0%) 0(0.0%) <.001 
SD*=standard deviation. †IQR=Interquartile Range. ‡NA=Not available. 
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Table S5. The Associations of the Covariates with the Hazard of Any Childhood Mental Disorder in the 
Offspring. Hazard Ratios and 95% Confidence Intervals from Unadjusted Cox Proportional Hazards Models. 
Any Childhood Mental Disorder in the Offspring 
Characteristic HR(95 % CI)* p 
Maternal Characteristics 




Primary or Secondary vs. Lower Tertiary 
Primary or Secondary vs. Upper Tertiary 
Lower Tertiary vs. Upper Tertiary .01 
Body Mass Index in Early Pregnancy <.001 
.49 
<.001 
Underweight vs. normal weight 
Overweight vs. normal weight 













Parity: Primiparous vs. Multiparous 
Lifetime Diagnosis of Any Mental Disorder (yes vs. no) 
Alcohol Use During Pregnancy (yes vs. no) 
Smoking During Pregnancy 
.49 
<.001 
Quit during 1st trimester vs. no smoking  
Smoked throughout pregnancy vs. no smoking 





Diabetes in Previous Pregnancy vs. no diabetes .76 1.12(0.55-2.25) 
1.84(1.45-2.33) <.001  Diabetes in Current Pregnancy vs. no diabetes 
Paternal Characteristics 
Lifetime Diagnosis of Any Mental Disorder (yes vs. no) .003 1.99(1.26-3.15) 
1.23(0.46-3.32) .68  Lifetime Diagnosis of Any Hypertensive Disorder (yes vs. no) 
Child Characteristics 
<.001 Sex (Boys vs. Girls) 
Gestational age .09 
.01  Preterm vs. Other 
Birthweight Adjusted for Gestation Length and Sex .68 
.05  Small for Gestational Age vs. Other 







Birth Year 0.93(0.82-1.06) .29 
*HR= Hazard Ratio; 95%CI= 95% Confidence Interval.
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Table S6. Sensitivity Analyses of Maternal Hypertensive Disorders, Blood Pressure and Adverse Pregnancy Conditions and the Hazard of Childhood Mental 
Disorders in the Offspring. Mothers with Coronary Heart Disease or Stroke by Childbirth or Genitourinary Infections during Pregnancy Were Excluded.  
Offspring Mental Disorders 




Behavioral and Emotional 
Disorders 
HR(95 % CI)* p HR(95% CI)* p HR(95% CI)* p 
Maternal Hypertension Before Current Pregnancy vs. Normotension 0.77(0.49-1.20) .25 0.86(0.50-1.49) .60 0.50(0.24-1.08) .08 
Maternal Unspecified Hypertension in Current Pregnancy vs. Normotension 3.40(0.48-24.21) .22 5.74(0.80-40.98) .08 0(NA)* .96 
Maternal Chronic Hypertension in Current Pregnancy vs. Normotension 1.51(1.00-2.28) .05 1.84(1.12-2.99) .02 1.42(0.78-2.57) .25 
Maternal Gestational Hypertension in Current Pregnancy vs. Normotension 1.49(1.04-2.15) .03 1.66(1.05-2.61) .03 1.21(0.68-2.13) .52 
Maternal Preeclampsia in Current Pregnancy vs. Normotension 1.91(1.32-2.76) .001 2.18(1.39-3.44) .001 2.21(1.35-3.62) .002 
Maternal Mild/Moderate Preeclampsia in Current Pregnancy vs. Normotension 1.66(1.00-2.75) .05 1.90(1.03-3.50) .04 2.09(1.10-3.97) .02 
Maternal Severe Preeclampsia in Current Pregnancy vs. Normotension 2.25(1.23-4.13) .01 2.41(1.12-5.17) .02 2.94(1.37-6.33) .01 
Maternal Systolic Blood Pressure during Current Pregnancy†‡ 1.19(1.00-1.42) .05 1.26(1.01-1.58) .04 1.18(0.92-1.52) .18 
Maternal Diastolic Blood Pressure during Current Pregnancy †‡ 1.13(0.94-1.35) .19 1.16(0.92-1.46) .22 1.06(0.82-1.38) .64 
Number of Maternal Adverse Pregnancy Conditions§ 
 1 vs. 0 1.50(1.17-1.91) .001 1.50(1.10-2.05) .01 1.43(1.01-2.03) .05 
 2 vs. 0 2.09(1.56-2.80) <.001 2.64(1.86-3.74) <.001 2.03(1.33-3.10) .001 
 3 vs. 0 3.22(2.20-4.72) <.001 3.16(1.91-5.22) <.001 3.85(2.31-6.42) <.001 
*HR=Hazard Ratio. 95%CI=95% Confidence Interval. NA=Not available.
All the analyses are stratified for offspring sex and adjusted for offspring birth year. 
*Systolic blood pressure values were natural logarithm transformed to obtain normality.
†Both maternal systolic and diastolic blood pressure values during current pregnancy are expressed in standard deviation units to facilitate comparison of effect sizes. 
§Maternal adverse pregnancy conditions are defined as overweight/obesity, diabetes and hypertensive disorders in pregnancy. Normal weight, normotensive women with
no diabetes disorders are the reference group. 
Figure S1. Mediation analyses on preterm and small for gestational age births and neonatal intensive care unit admission as mediators of the effects of maternal preeclampsia on offspring psychological development disorders (Panels A-B) and any and severe
preeclampsia on offspring behavioral and emotional disorders (Panels C-F). Small for gestational age birth did not predict offspring behavioral and emotional disorders (p=.07), severe preeclampsia was not independently associated with offspring psychological 
development disorders (p=.054) and preterm birth did not predict offspring psychological development disorders when adjusting for maternal preeclampsia (p=.08). Hence, these mediation pathways were not tested. Standardized regression coefficients (β) and 95 % 
Confidence Intervals (CI) from logistic regressions and Sobel’s Tests. 
